Payal Kohli, MD, FACC

Payal Kohli

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Grand Rounds(SIGNIFICANT), Amgen(MODEST), GE/Skyword(SIGNIFICANT), American College of Cardiology(MODEST), 2nd MD(SIGNIFICANT), GE Skyword(SIGNIFICANT), Viz.ai(SIGNIFICANT), Included Health(MODEST), HeartFlow(SIGNIFICANT), Merck(MODEST), Biofourmis(MODEST), Family Heart(MODEST), P-Value Communications(MODEST), NovoNordisk(SIGNIFICANT), Healthy Women(MODEST), Heart Flow (SIGNIFICANT), Idorsia(MODEST), Strafulence(MODEST) SPEAKER'S BUREAU: Amarin(SIGNIFICANT), Merck(SIGNIFICANT), Astra Zeneca(MODEST), Bristol-Myers Squibb Company(SIGNIFICANT), ZOLL(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Clinical Options(MODEST), ROCHESTER REGIONAL HEALTH(MODEST) OFFICER, DIRECTOR ETC: Cherry Creek Heart(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Doximity(MODEST) RESEARCH/RESEARCH GRANTS: Transcend(MODEST) SALARY: Tegna Central and other Tegna stations(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT), Daily Blast Live(NONE), Novartis(SIGNIFICANT), The Medical Center of Aurora(NONE), Agepha Pharma(MODEST), Medpage(MODEST), 9News/Tegna(SIGNIFICANT), Medscape(MODEST), LEXICON PHARMACEUTICALS, INC.(SIGNIFICANT)

View Full Disclosure